|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 362.40 SEK | +2.55% |
|
+2.93% | -0.52% |
| 04:48am | EQT in Talks to Acquire Oxford Biomedical | FW |
| 12:38am | UK Stocks-Factors to watch on January 15 | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | 379M | 909M | 176M | 130M | 776M | ||||
Depreciation & Amortization - CF | 20.4M | 23.6M | 35.2M | 45.8M | 54M | ||||
Amortization of Goodwill and Intangible Assets - (CF) | 9M | 63.2M | 155M | 364M | 365M | ||||
Depreciation & Amortization, Total | 29.4M | 86.8M | 190M | 410M | 419M | ||||
Amortization of Deferred Charges, Total - (CF) | 5.7M | 5.5M | 7.2M | 8.3M | 17.2M | ||||
(Gain) Loss on Sale of Investments - (CF) | -16.1M | -72.8M | -5.9M | -22.5M | -273M | ||||
Asset Writedown & Restructuring Costs | - | -500K | - | - | - | ||||
Net Cash From Discontinued Operations | -18.7M | - | - | - | - | ||||
Other Operating Activities, Total | -105M | 3.5M | 260M | 523M | -540M | ||||
Change In Accounts Receivable | -131M | -430M | -96.6M | -122M | -30.4M | ||||
Change In Accounts Payable | 12.5M | 106M | 18.1M | 17.6M | 95.5M | ||||
Cash from Operations | 157M | 608M | 549M | 945M | 464M | ||||
Capital Expenditure | -8.3M | -11.5M | -30.8M | -23.1M | -17.5M | ||||
Cash Acquisitions | - | -632M | -1.46B | - | - | ||||
Sale (Purchase) of Intangible assets | -100K | - | -200K | -500K | - | ||||
Investment in Marketable and Equity Securities, Total | -107M | -236M | -60.4M | -39.7M | - | ||||
Other Investing Activities, Total | 136M | -16.6M | -700K | 24.5M | 15.8M | ||||
Cash from Investing | 20.6M | -895M | -1.55B | -38.8M | -1.7M | ||||
Short Term Debt Issued, Total | - | - | - | - | - | ||||
Long-Term Debt Issued, Total | - | 496M | 1.48B | - | - | ||||
Total Debt Issued | - | 496M | 1.48B | - | - | ||||
Short Term Debt Repaid, Total | -9.4M | - | - | - | - | ||||
Long-Term Debt Repaid, Total | -14.4M | -274M | -38.1M | -31.6M | -38.6M | ||||
Total Debt Repaid | -23.8M | -274M | -38.1M | -31.6M | -38.6M | ||||
Issuance of Common Stock | - | - | - | 500K | - | ||||
Repurchase of Common Stock | - | - | - | -38M | -118M | ||||
Common Dividends Paid | -197M | -234M | -291M | -298M | -373M | ||||
Common & Preferred Stock Dividends Paid | -197M | -234M | -291M | -298M | -373M | ||||
Other Financing Activities, Total | 4.7M | -8.2M | -9M | -47.7M | -44.7M | ||||
Cash from Financing | -216M | -20.3M | 1.14B | -415M | -574M | ||||
Foreign Exchange Rate Adjustments | 8.2M | 17.2M | -89.6M | -21.7M | 21.6M | ||||
Miscellaneous Cash Flow Adjustments | -100K | - | 100K | - | - | ||||
Net Change in Cash | -30.6M | -290M | 57.1M | 469M | -90.1M | ||||
Supplemental Items | |||||||||
Cash Interest Paid | 4.7M | 8M | 8.7M | 47.7M | 44.7M | ||||
Cash Income Tax Paid (Refund) | 35.4M | 46.3M | 99.2M | 105M | 130M | ||||
Levered Free Cash Flow | 124M | 222M | -366M | 1.22B | 1.48B | ||||
Unlevered Free Cash Flow | 127M | 228M | -339M | 1.26B | 1.51B | ||||
Change In Net Working Capital | 105M | 466M | 897M | -419M | -392M | ||||
Net Debt Issued / Repaid | -23.8M | 222M | 1.44B | -31.6M | -38.6M |
Select your edition
All financial news and data tailored to specific country editions
















